2014
1
Anazawa T., Saito T., Goto M., Kenmochi T., Uemoto S., Ito T., Yasunami Y., Kenjo A., Kimura T., Ise K., Tsuchiya T., Gotoh M. Long-term outcomes of clinical transplantation of pancreatic islets with uncontrolled donors after cardiac death: a multicenter experience in Japan. Transplant Proc 46 1980-1984 2014
2
Akamatsu N., Sugawara Y., Kokudo N., Eguchi S., Fujiwara T., Ohdan H., Nagano H., Taketomi A., Kitagawa Y., Shimada M., Ku Y., Yanaga K., Shirabe K., Ikegami T., Mizokami M., Takeuchi M., Maehara Y. Outcomes of living donor liver transplantation for HCV-positive recipients in Japan: results of a nationwide survey. Transpl Int 27 767-774 2014
3
Arakai T., Okita Y., Uchino M., Ikeuchi H., Sasaki I., Funayama Y., Fukushima K., Futami K., Maeda K., Iiai T., Itabashi M., Hase K., Motoya S., Kitano A., Mizushima T., Maeda K., Kobayashi M., Mohri Y., Kusunoki M. Risk factors for surgical site infection in Japanese patients with ulcerative colitis: a multicenter prospective study. Surg Today 44 1072-1078 2014
4
Colvin H., Nishida N., Koseki J., Konno M., Kawamoto K., Tsunekuni K., Doki Y., Mori M., Ishii H. Cancer Stem Cells of the Digestive System. Jpn J Clin Oncol 12 1141-1149 2014
5
Egawa H., Teramukai S., Haga H., Tanabe M., Mori A., Ikegami T., Kawagishi N., Ohdan H., Kasahara M., Umeshita K. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study. Am J Transplant 14 102-114 2014
6
Egawa H., Nishimura K., Teramukai S., Yamamoto M., Umeshita K., Furukawa H., Uemoto S. Risk factors for alcohol relapse after liver transplantation for alcoholic cirrhosis in Japan. Liver Transplant 20 298-310 2014
7
Eguchi H., Nagano H., Kobayashi S., Kawamoto K., Wada H., Hama N., Tomimaru Y., Akita H., Sakai D., Satoh T., Kudo T., Isohashi F., Mori M., Doki Y. A phase I trial of combination therapy using gemcitabine and S-1 concurrent with full-dose radiation for resectable pancreatic cancer. Cancer Chemother Pharmacol 73 309-315 2014
8
Endo S., Takiguchi S., Miyazaki Y., Nishikawa K., Imamura H., Takachi K., Kimura Y., Takeno A., Tamura S., Mori M., Doki Y. Efficacy of endoscopic gastroduodenal stenting for gastric outlet obstruction due to unresectable advanced gastric cancer: a prospective multicenter study. J Surg Oncol 109 208-212 2014
9
Fujita J., Takiguchi S., Nishikawa K., Kimura Y., Imamura H., Tamura S., Ebisui C., Kishi K., Fujitani K., Kurokawa Y., Mori M., Doki Y. Randomized controlled trial of the LigaSure vessel sealing system versus conventional open gastrectomy for gastric cancer. Surg Today 44 1723-1729 2014
10
Fujiwara Y., Okada K., Hanada H., Tamura S., Kimura Y., Fujita J., Imamura H., Kishi K., Yano M., Miki H., Okada K., Takayama O., Aoki T., Mori M., Doki Y. The clinical importance of a transcription reverse-transcription concerted (TRC) diagnosis using peritoneal lavage fluids in gastric cancer with clinical serosal invasion: a prospective, multicenter study. Surgery 155 417-423 2014
11
Fukusumi T., Ishii H., Konno M., Yasui T., Nakahara S., Takenaka Y., Yamamoto Y., Nishikawa S., Kano Y., Ogawa H., Hasegawa S., Hamabe A., Haraguchi N., Doki Y., Mori M., Inohara H. CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma. Br J Cancer 111 506-514 2014
12
Genda T., Ichida T., Sakisaka S., Sata M., Tanaka E., inui A., Egawa H., Umeshita K., Furukawa H., Kawasaki S., Inomata Y. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system. J Gastroenterol 49 324-331 2014
13
Hackman RM., Aggarwal BB., Applebaum RS., deVere White RW., Dubick MA., Heber D., Ito T., Johnson GH., Keen CL., Winters BL., Stohs SJ. Forecasting nutrition research in 2020. J Am Coll Nutr 33 340-346 2014
14
Hamabe A., Takemasa I., Uemura M., Nishimura J., Mizushima T., Ikeda M., Yamamoto H., Sekimoto M., Doki Y., Mori M. Feasibility of single-port laparoscopic surgery for sigmoid colon and rectal cancers and preoperative assessment of operative difficulty. J Gastrointest Surg 18 977-985 2014
15
Hamabe A., Yamamoto H., Konno M., Uemura M., Nishimura J., Hata T., Takemasa I., Mizushima T., Nishida N., Kawamoto K., Koseki J., Doki Y., Mori M., Ishii H. Combined evaluation of hexokinase 2 and phosphorylated pyruvate dehydrogenase-E1α in invasive front lesions of colorectal tumors predicts cancer metabolism and patient prognosis. Cancer Sci 105 1100-1108 2014
16
Hamabe A., Konno M., Tanuma N., Shima H., Tsunekuni K., Kawamoto K., Nishida N., Koseki J.,Mimori K.,Gotoh N., Yamamoto H., Doki Y., Mori M., Ishii H. Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition. Proc Natl Acad Sci USA 111 15526-15531 2014
17
Hara J., Miyata H., Yamasaki M., Sugimura K., Takahashi T., Kurokawa Y., Nakajima K., Takiguchi S., Mori M., Doki Y. Mesenchymal phenotype after chemotherapy is associated with chemoresistance and poor clinical outcome in esophageal cancer. Oncol Rep 31 589-596 2014
18
Hasegawa J., Nishimura J., Mizushima T., Miyake Y., Kim HM., Takemoto H., Tamagawa H., Noura S., Fujii M., Fujie Y., Kato T., Miwa H., Takemasa I., Ikeda M., Yamamoto H., Sekimoto M., Nezu R., Doki Y., Mori M. Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer. Cancer Chemother Pharmacol 73 1079-1087 2014
19
Hasegawa S., Eguchi H., Nagano H., Konno M., Tomimaru Y., Wada H., Hama N., Kawamoto K., Kobayashi S., Nishida N., Koseki J., Nishimura T., Gotoh N., Ohno S., Yabuta N., Nojima H., Mori M., Doki Y., Ishii H. MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer.
Br J Cancer 111 1572-1580 2014
20
Hata T., Yasui M., Murata K., Okuyama M., Ohue M., Ikeda M., Ueshima S., Kitani K., Hasegawa J., Tamagawa H., Fujii M., Ohkawa A., Kato T., Morita S., Fukuzaki T., Mizushima T., Sekimoto M., Nezu R., Doki Y., Mori M. Safety of fondaparinux to prevent venous thromboembolism in Japanese patients undergoing colorectal cancer surgery: a multicenter study. Surg Today 44 2116-2123 2014
21
Hayashi K., Tamari K., Ishii H., Konno M., Nishida N., Kawamoto K., Koseki J., Fukusumi T., Kano Y., Nishikawa S., Miyo M., Noguchi K., Ogawa H., Hamabe A., Seo Y., Doki Y., Mori M., Ogawa K. Visualization and characterization of cancer stem-like cells in cervical cancer. Int J Oncol 45 2468-2474 2014
22
Hiraki M., Nishimura J., Ohtsuka M., Shiomi H., Uemura M., Haraguchi N., Hata T., Hayashi T., Takemasa I., Mizushima T., Isohashi F., Yoshioka Y., Ogawa K., Doki Y., Mori M., Yamamoto H. Impact of stereotactic body radiotherapy on colorectal cancer with distant metastases. Oncol Rep 31 795-799 2014
23
Hiraki M., Takemasa I., Uemura M., Haraguchi N., Nishimura J., Hata T., Mizushima T., Yamamoto H., Doki Y., Mori M. Evaluation of invasiveness in single-site laparoscopic colectomy, using the PainVision™ system for quantitative analysis of pain sensation. Surg Endosc 28 3216-3223 2014
24
Hirota M., Kato M., Yamasaki M., Kawai N., Miyazaki Y., Yamada T., Takahashi T., Takehara T., Mori M., Doki Y., Nakajima K. A novel endoscopic submucosal dissection technique with robust and adjustable tissue traction. Endoscopy 46 499-502 2014
25
Hirota M., Miyazaki Y., Takahashi T., Yamasaki M., Takiguchi S., Mori M., Doki Y., Nakajima K. Steady Pressure CO2 Colonoscopy: Its Feasibility and Underlying Mechanism. Dis Colon Rectum 57 1120-1128 2014
26
Horise Y., Matsumoto T., Ikeda H., Nakamura Y., Yamasaki M., Sawada G., Tsukao Y., Nakahara Y., Yamamoto M., Takiguchi S., Doki Y., Mori M., Miyazaki F., Sekimoto M., Kawai T., Nishikawa A. A novel locally operated master-slave robot system for single-incision laparoscopic surgery. Minim Invasive Ther Allied Technol 23 326-332 2014
27
Ikezawa K., Kanai M., Ajiki T., Tsukamoto T., Toyokawa H., Terajima H., Furuyama H., Nagano H., Ikai I., Kuroda N., Awane M., Ochiai T., Takemura S., Miyamoto A., Kume M., Ogawa M., Takeda Y., Taira K., Ioka T. Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy. J Hepatobiliary Pancreat Sci 29 98-104 2014
28
Inoue A., Akita H., Eguchi H., Hama N., Wada H., Kawamoto K., Kobayashi S., Mori M., Doki Y., Nagano H. Gastric conduit-preserving, radical pancreaticoduodenectomy with microvascular reconstruction for pancreatic head cancer after esophagectomy: report of a case. Surg Today 44 786-791 2014
29
Inoue A., Uemura M., Yamamoto H., Hiraki M., Naito A., Ogino T., Nonaka R., Nishimura J., Wada H., Hata T., Takemasa I., Eguchi H., Mizushima T., Nagano H., Doki Y., Mori M. Short-term outcomes of simultaneous laparoscopic colectomy and hepatectomy for primary colorectal cancer with synchronous liver metastases. Int Surg 99 338-343 2014
30
Ito T., Urushima H., Sakaue M., Yukawa S., Honda H., Hirai K., Igura T., Hayashi N., Maeda K., Kitagawa T., Kondo K. Reduction of adverse effects by a mushroom product, active hexose correlated compound (AHCC) in patients with advanced cancer during chemotherapy--the significance of the levels of HHV-6 DNA in saliva as a surrogate biomarker during chemotherapy. Nutr Cancer 66 377-382 2014
31
Iwagami Y., Eguchi H, Wada H, Tomimaru Y, Hama N, Kawamoto K, Kobayashi S, Mori M, Doki Y, Nagano H. Implications of peritoneal lavage cytology in resectable left-sided pancreatic cancer. Surg Today Epub - 2014
32
Kano Y., Ishii H., Konno M., Yamasaki M., Miyata H., Nishikawa S., Hamabe A., Ogawa H., Takahashi H., Ohta K., Hasegawa S., Tanaka K., Fukusumi T., Otsuka M., Kawamoto K., Haraguchi N., Fujimoto R., Isobe M., Tomita Y., Matsuura N., Takiguchi S., Mori M., Doki Y. Cells of origin of squamous epithelium, dysplasia and cancer in the head and neck region after bone marrow transplantation. Int J Oncol 44 443-450 2014
33
Kano Y., Konno M., Kawamoto K., Tamari K., Hayashi K., Fukusumi T., Satoh T., Tanaka S., Ogawa K., Mori M., Doki Y., Ishii H. Novel drug discovery system for cancer stem cells in human squamous cell carcinoma of the esophagus. Oncol Rep 31 1133-1138 2014
34
Kasahara M., Sakamoto S., Umeshita K., Uemoto S. Effect of graft size matching on pediatric living-donor liver transplantation in Japan. Exp Clin Transplant 12 1-4 2014
35
Kato M., Nakajima K., Yamada T., Hirota M., Miyazaki Y., Yamasaki M., Nishida T., Mori M., Doki Y., Tujii M., Takehara T. Esophageal submucosal dissection under steady pressure automatically controlled endoscopy (SPACE) : a clinical feasibility study. Endoscopy 46 680-684 2014
36
Kato T., Okumi M., Tanemura M., Yazawa K., Kakuta Y., Yamanaka K., Tsutahara K., Doki Y., Mori M., Takahara S., Nonomura N. Adipose tissue-derived stem cells suppress acute cellular rejection by TSG-6 and CD44 interaction in rat kidney transplantation. Transplantation 98 277-284 2014
37
Kenjo A., Miyata H., Gotoh M., Kitagawa Y., Shimada M., Baba H., Tomita N., Kimura W., Sugihara K., Mori M. Risk stratification of 7,732 hepatectomy cases in 2011 from the National Clinical Database for Japan. J Am Coll Surg 218 412-422 2014
38
Kida H., Takano Y., Yamamoto K., Mori M., Yanaga K., Tanaka J., Kudo SE., Mimori K. A single nucleotide polymorphism in fibronectin 1 determines tumor shape in colorectal cancer. Oncol Rep 32 548-552 2014
39
Kimura W., Miyata H., Gotoh M., Hirai I., Kenjo A., Kitagawa Y., Shimada M., Baba H., Tomita N., Nakagoe T., Sugihara K., Mori M. A pancreaticoduodenectomy risk model derived from 8575 cases from a national single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomy. Ann Surg 259 773-780 2014
40
Kita Y., Nishizono Y., Okumura H., Uchikado Y., Sasaki K., Matsumoto M., Setoyama T., Tanoue K., Omoto I., Mori S., Owaki T., Ishigami S., Nakagawa H., Tanaka F., Mimori K., Mori M., Natsugoe S. Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma. Oncol Rep 31 1986-1992 2014
41
Kitahara T., Uemura M., Haraguchi N., Nishimura J., Shingai T., Hata T., Takemasa I., Mizushima T., Doki Y., Mori M., Yamamoto H. Successful treatment of rectal cancer with perineal invasion: Three case reports. Mol Clin Oncol 2 497-500 2014
42
Kobayashi H., Miyata H., Gotoh M., Baba H., Kimura W., Kitagawa Y., Nakagoe T., Shimada M., Tomita N., Sugihara K., Mori M. Risk model for right hemicolectomy based on 19,070 Japanese patients in the National Clinical Database. J Gastroenterol 49 1047-1055 2014
43
Koga C., Kobayashi S., Nagano H., Tomimaru Y., Hama N., Wada H., Kawamoto K., Eguchi H., Konno M., Ishii H., Umeshita K., Doki Y., Mori M. Reprogramming Using microRNA-302 Improves Drug Sensitivity in Hepatocellular Carcinoma Cells. Ann Surg Oncol 21 591-600 2014
44
Komeda K., Hayashi M., Kubo S., Nagano H., Nakai T., Kaibori M., Wada H., Takemura S., Kinoshita M., Koga C., Matsumoto M., Sakaguchi T., Inoue Y., Hirokawa F., Kwon AH., Uchiyama K. High Survival in Patients Operated for Small Isolated Liver Metastases from Gastric Cancer: A Multi-institutional Study. World J Surg 38 2692-2697 2014
45
Kou T., Kanai M., Ikezawa K., Ajiki T., Tsukamoto T., Toyokawa H., Yazumi S., Terajima H., Furuyama H., Nagano H., Ikai I., Kuroda N., Awane M., Ochiai T., Takemura S., Miyamoto A., Kume M., Ogawa M., Takeda Y., Taira K., Ioka T. Comparative Outcomes of Elderly and Non-elderly Patients Receiving First-Line Palliative Chemotherapy for Advanced Biliary Tract Cancer. J Gastroenterol Hepatol 29 403-408 2014
46
Kubo S., Uemoto S., Furukawa H., Umeshita K., Tachibana D. Pregnancy outcomes after living donor liver transplantation: results from a Japanese survey. Liver Transplant 20 576-583 2014
47
Kurokawa Y., Sugimoto N., Miwa H., Tsuda M., Nishina S., Okuda H., Imamura H., Gamoh M., Sakai D., Shimokawa T., Komatsu Y., Doki Y., Tsujinaka T., Furukawa H. Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1). Br J Cancer 110 1163-1168 2014
48
Kurokawa Y., Shibata T., Sasako M., Sano T., Tsuburaya A., Iwasaki Y., Fukuda H. Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A). Gastric Cancer 17 514-521 2014
49
Kurokawa Y., Matsuura N., Kawabata R., Nishikawa K., Ebisui C., Yokoyama Y., Shaker MN., Hamakawa T., Takahashi T., Takiguchi S., Mori M., Doki Y. Prognostic Impact of Major Receptor Tyrosine Kinase Expression in Gastric Cancer. Ann Surg Oncol 21 584-590 2014
50
Lin H., Maeda K., Fukuhara A., Shimomura I., Ito T. Molecular expression of adiponectin in human saliva. Biochem Biophys Res Commun 445 294-298 2014
51
Maeda S., Wada H., Naito Y., Nagano H., Simmons S., Kagawa Y., Naito A., Kikuta J., Ishii T., Tomimaru Y., Hama N., Kawamoto K., Kobayashi S., Eguchi H., Umeshita K., Ishii H., Doki Y., Mori M., Ishii M. Interferon-α acts on the S/G2/M phases to induce apoptosis in the G1 phase of an IFNAR2-expressing hepatocellular carcinoma cell line. J Biol Chem 289 23786-23795 2014
52
Marubashi S., Gotoh K., Takahashi H., Ohigashi H., Yano M., Ishikawa O., Sakon M. Prediction of the postoperative prognosis of intrahepatic cholangiocarcinoma (ICC): importance of preoperatively- determined anatomic invasion level and number of tumors. Dig Dis Sci 59 201-213 2014
53
Marubashi S., Wada H., Kawamoto K., Kobayashi S., Eguchi H., Doki Y., Mori M., Nagano H. Laparoscopy-assisted hybrid left-side donor hepatectomy: rationale for performing LADH. World J Surg 38 1562-1563 2014
54
Masuzawa T., Takiguchi S., Hirao M., Imamura H., Kimura Y., Fujita J., Miyashiro I., Tamura S., Hiratsuka M., Kobayashi K., Fujiwara Y., Mori M., Doki Y. Comparison of perioperative and long-term outcomes of total and proximal gastrectomy for early gastric cancer: a multi-institutional retrospective study. World J Surg 38 1100-1106 2014
55
Matsubara N., Miyata H., Gotoh M., Tomita N., Baba H., Kimura W., Nakagoe T., Simada M., Kitagawa Y., Sugihara K., Mori M. Mortality after common rectal surgery in Japan: a study on low anterior resection from a newly established nationwide large-scale clinical database. Dis Colon Rectum 57 1075-1081 2014
56
Matsumoto K., masato M., Yamazaki Y., Tanaka H., Watanabe M., Eguchi H., Nagano H., Hikita H., Tatsumi T., Takehara T., Tamura A., Tsukita S. Claudin 2 deficiency reduces bile flow and increases susceptibility to cholesterol gallstone disease in mice. Gastroenterology 147 1134-1145 2014
57
Matsumura T., Sugimachi K., Takahashi Y., Uchi R., Sawada G., Ueda M., Hirata H., Sakimura S., Ueo H., Takano Y., Kurashige J., Shinden Y., Eguchi H., Sudo T., Yamamoto H., Doki Y., Mori M., Mimori K. Clinical Significance of GAB2, a Scaffolding/Docking Protein Acting Downstream of EGFR in Human Colorectal Cancer. Ann Surg Oncol 743-749 2014
58
Miyata H., Yamasaki M., Takahashi T., Murakami K., Tanaka K., Yukinori K., Nakajima K., Takiguchi S., Morii E., Hatazawa J., Mori M., Doki Y. Determinants of response to neoadjuvant chemotherapy for esophageal cancer using 18F-fluorodeoxiglucose positron emission tomography (18F-FDG-PET). Ann Surg Oncol 21 575-582 2014
59
Miyazaki Y., Nakajima K., Sumikawa M., Yamasaki M., Takahashi T., Miyata H., Takiguchi S., Kurokawa Y., Tomiyama N., Mori M., Doki Y. Magnetic resonance imaging for simultaneous morphological and functional evaluation of esophageal motility disorders. Surg Today 44 668-676 2014
60
Miyoshi N., Yamamoto H., Mimori K., Yamashita S., Miyazaki S., Nakagawa S., Ishii H., Noura S., Ohue M., Yano M., Doki Y., Mori M. ANXA9 gene expression in colorectal cancer: A novel marker for prognosis. Oncol Lett 8 2313-2317 2014
61
Mizote Y, Uenaka A., Isobe M., Wada H., Kakimi K., Saika T., Kita S., Koide Y., Oka M., Nakayama E. Production of NY-ESO-1 peptide/DRB1*08:03 tetramers and ex vivo detection of CD4 T-cell responses in vaccinated cancer patients. Vaccine 32 957-964 2014
62
Mori M., The JSGS president's message: for the development of the cooperation between the JSGS and the SSO. Ann Surg Oncol 21 345-347 2014
63
Morimoto A, Morimoto A., Serada S., Enomoto T., Kim A., Matsuzaki S., Takahashi T., Ueda Y., Yoshino K., Fujita M., Fujimoto M., Kimura T., Naka T. Annexin A4 induces platinum resistance in a chloride-and calcium-dependent manner. Oncotarget 15 7776-7787 2014
64
Morooka Y., Umeshita K. Perceptions of transplant surgery among living liver donors in Japan. Prog Transplant 24 381-386 2014
65
Motoi F., Unno M., Takahashi H., Okada T., Wada K., Sho M., Nagano H., Matsumoto I., Satoi S., Murakami Y., Kishiwada M., Honda G., Kinoshita H., Baba H., Hishinuma S., Kitago M., Tajima H., Shinchi H., Takamori H., Kosuge T., Yamaue H., Takada T. Influence of preoperative anti-cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: Project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 21 148-158 2014
66
Mukai A., Iijima H., Hiyama S., Fujii H., Shinzaki S., Inoue T., Shiraishi E., Kawai S., Araki M., Hayashi Y., Kondo J., Mizushima T., Kanto T., Egawa S., Nishida T., Tsujii M., Takehara T. Regulation of anergy-related ubiquitin E3 ligase, GRAIL, in murine models of colitis and patients with Crohn's disease. J Gastroenterol 49 1524-1535 2014
67
Munakata K., Uemura M., Takemasa I., Ozaki M., Konno M., Nishimura J., Hata T., Mizushima T., Haraguchi N., Noura S., Ikenaga M., Okamura S., Fukunaga M., Murata K., Yamamoto H., Doki Y., Mori M.. SCGB2A1 is a novel prognostic marker
for colorectal cancer associated with
chemoresistance and radioresistance. Int J Oncol 44 1521-1528 2014
68
Murata K., Yamamoto H., Fukunaga M., Kato T., Ohnishi T., Uemura Y., Ohta H., Kimura F., Ohue M., Nezu R., Sekimoto M., Ikeda M., Mizushimaz T., Doki Y., Mori M. Survival benefit of oral tegafur/uracil and leucovorin as a first line therapy for elderly patients with advanced or metastatic colorectal cancer. Hepatogastroenterology 61 94-98 2014
69
Mydlarz W., Uemura M., Ahn S., Hennessey P., Chang S., Demokan S., Sun W., Shao C., Bishop J., Krosting J., Mambo E., Westra W., Ha P., Sidransky D., Califano J. Clusterin is a gene-specific target of microRNA-21 in head and neck squamous cell carcinoma. Clin Cancer Res 20 868-877 2014
70
Nakashima S., Kobayashi S., Sakai D., Tomokuni A., Tomimaru Y., Hama N., Wada H., Kawamoto K., Marubashi S., Eguchi H., Matsuura N., Doki Y., Mori M., Nagano H. Prognostic Impact of Tumoral and/or Peri-Tumoral Stromal SPARC Expressions After Surgery in Patients With Biliary Tract Cancer.
J Surg Oncol 110 1016-1022 2014
71
Nishida S., Koido S., Takeda Y., Homma S., Komita H., Takahara A., Morita S., Ito T., Morimoto S., Hara K., Tsuboi A., Oka Y., Yanagisawa S., Toyama Y., Ikegami M., Kitagawa T., Eguchi H., Wada H., Nagano H., Nakata J., Nakae Y., Hosen N., Oji Y., Tanaka T., Kawase I., Kumanogoh A., Sakamoto J., Doki Y., Mori M., Ohkusa T., Tajiri H., Sugiyama H. Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer. J Immunother 37 105-114 2014
72
Nishida S., Koido S., Takeda Y., Homma S., Komita H., Takahara A., Morita S., Ito T., Morimoto S., Hara K., Tsuboi A., Oka Y., Yanagisawa S., Toyama Y., Ikegami M., Kitagawa T., Eguchi H., Wada H., Nagano H., Nakata J., Nakae Y., Hosen N., Oji Y., Tanaka T., Kawase I., Kumanogoh A., Sakamoto J., Doki Y., Mori M., Ohkusa T., Tajiri H., Sugiyama H. Wilms Tumor Gene (WT1) Peptide-based Cancer Vaccine Combined With Gemcitabine for Patients With Advanced Pancreatic Cancer. J Immunother 37 105-114 2014
73
Nonaka R., Nishimura J., Kagawa Y., Osawa H., Hasegawa J., Murata K., Okamura S., Uemura M., Hata T., Takemasa I., Mizushima T., Okuzaki D., Yamamoto H., Doki Y., Mori M. Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer. Oncol Rep 32 2354-2358 2014
74
Ogawa H., Mizushima T., Takemasa I., Yamamoto H., Doki Y., Mori M. Short-term clinical outcomes of postoperative intrapelvic bleeding after extended pelvic surgery: a single institute experience. Anticancer Res 34 3169-3176 2014
75
Ogino T., Takemasa I., Horitsugi G., Furuyashiki M., Ohta K., Uemura M., Nishimura J., Hata T., Mizushima T., Yamamoto H., ,Doki Y., Mori M. Preoperative Evaluation of Venous Anatomy in Laparoscopic
Complete Mesocolic Excision for Right Colon Cancer. Ann Surg Oncol 21 429-435 2014
76
Ohta K., Takemasa I., Uemura M., Nishimura J., Mizushima T., Ikeda M., Yamamoto H., Sekimoto M., Doki Y., Mori M. Laparoscopic surgery for stage IV colorectal cancer. Surg Laparosc Endosc Percutan Tech 24 153-157 2014
77
Ohue Y., Wada H., Oka M., Nakayama E. Antibody response to cancer/testis (CT) antigens: A prognostic marker in cancer patients. OncoImmunology 3 - 2014
78
Okano M., Konno M., Kano Y., Kim H., Kawamoto K., Ohkuma M., Haraguchi N., Yokobori T., Mimori K., Yamamoto H., Sekimoto M., Doki Y., Mori M., Ishii H. Human colorectal CD24+ cancer stem cells are susceptible to epithelial-mesenchymal transition. Int J Oncol 45 575-580 2014
79
Saito T., Wada H., Yamasaki M., Miyata H., Nishikawa H., Sato E., Kageyama S., Shiku H., Mori M., Doki Y. High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine. Vaccine 32 5901-5907 2014
80
Saito T., Kurokawa Y., Takiguchi S., Masaki M., Doki Y. Current status of function-preserving surgery for gastric cancer. World J Gastroenterol 20 17297-17304 2014
81
Sakamoto S., Kasahara M., Mizuta K., Kuroda T., Yagi T., Taguchi T., Inomata Y., Umeshita K., Uemoto S. Nationwide survey of the outcomes of living donor liver transplantation for hepatoblastoma in Japan. Liver Transplant 20 333-346 2014
82
Sueda T., Kudo T., Sakai D., Uemura M., Nishimura J., Hata T., Takemasa I., Mizushima T., Yamamoto H., Ezoe S., Matsumoto K., Doki Y., Mori M., Satoh T. Safety and pharmacokinetics of S-1 in a recurrent colon cancer patient with chronic myeloid leukemia treated with dasatinib: a case report. Cancer Chemother Pharmacol 74 1321-1324 2014
83
Sugimachi K., Yokobori T., Iinuma H., Ueda M., Ueo H., Shinden Y., Eguchi H., Sudo T., Suzuki A., Maehara Y., Mori M., Mimori K. Aberrant expression of plastin-3 via copy number gain induces the epithelial-mesenchymal transition in circulating colorectal cancer cells. Ann Surg Oncol 21 3680-3690 2014
84
Sugimura K., Miyata H., Yamasaki M., Takahashi T., Kurokawa Y., Motoori M., Nakajima K., Takiguchi S., Morii E., Yano M., Mori M., Doki Y. Clinical significance of muscle layer interruption in T3 esophageal
cancer. Esophagus 11 117-125 2014
85
Takahashi Y., Sawada G., Kurashige J., Uchi R., Matsumura T., Ueo H., Takano Y., Eguchi H., Sudo T., Sugimachi K., Yamamoto H., Doki Y., Mori M., Mimori K. Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. Br J Cancer 110 164-171 2014
86
Takahashi Y., Iwaya T., Sawada G., Kurashige J., Matsumura T., Uchi R., Ueo H., Takano Y., Eguchi H., Sudo T., Sugimachi K., Yamamoto H., Doki Y., Mori M., Mimori K. Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer. Ann Surg Oncol 21 205-212 2014
87
Takata A., Nakajima K., Kurokawa Y., Takahashi T., Yamasaki M., Miyata H., Takiguchi S., Mori M., Doki Y. Single-incision laparoscopic partial gastrectomy for gastric submucosal tumors without compromising transumbilical stapling. Asian J Endosc Surg. 7 25-30 2014
88
Takata A., Takiguchi S., Okada K., Takahashi T., Kurokawa Y., Yamasaki M., Miyata H., Nakajima K., Mori M., Doki Y. Clinicopathological and Prognostic Significance of FOXM1 Expression in Esophageal Squamous Cell Carcinoma. Anticancer Res 34 2427-2432 2014
89
Takata A., Kurokawa Y., Fujiwara Y., Nakamura Y., Takahashi T., Yamasaki M., Miyata H., Nakajima K., Takiguchi S., Mori M., Doki Y. Prognostic value of CEA and CK20 mRNA in the peritoneal lavage fluid of patients undergoing curative surgery for gastric cancer. World J Surg 38 1107-1111 2014
90
Takata A., Takiguchi S., Okada K., Takahashi T., Kurokawa Y., Yamasaki M., Miyata H., Nakajima K., Mori M., Doki Y. Expression of insulin-like growth factor-II mRNA-binding protein-3 as a marker for predicting clinical outcome in patients with esophageal squamous cell carcinoma. Oncol Lett 8 2027-2031 2014
91
Takeda Y., Nakamori S., Eguchi H., Kobayashi S., Marubashi S., Tanemura M., Konishi K., Yoshioka Y., Umeshita K., Mori M., Doki Y., Nagano H. Neoadjuvant Gemcitabine-based Accelerated Hyperfractionation Chemoradiotherapy for Patients with Borderline Resectable Pancreatic Adenocarcinoma. Jpn J Clin Oncol 44 1172-1180 2014
92
Takemasa I., Uemura M., Nishimura J., Mizushima T., Yamamoto H., Ikeda M., Sekimoto M., Doki Y., Mori M. Feasibility of single-site laparoscopic colectomy with complete mesocolic excision for colon cancer: a prospective case-control comparison. Surg Endosc 28 1110-1118 2014
93
Takeuchi H., Miyata H., Gotoh M., Kitagawa Y., Baba H., Kimura W., Tomita N., Nakagoe T., Shimada M., Sugihara K., Mori M. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg 260 259-266 2014
94
Takeyama H., Yamamoto H., Yamashita S., Wu X., Takahashi H., Nishimura J., Haraguchi N., Miyake Y., Suzuki R., Murata K., Ohue M., Kato T., Takemasa ., Mizushima T., Ishii H., Mimori K., Doki Y., Mori M. Decreased miR-340 expression in bone marrow is associated with liver metastasis of colorectal cancer. Mol Cancer Ther 13 976-985 2014
95
Takeyama H., Hata T., Nishimura J., Nonaka R., Uemura M., Haraguchi N., Takemasa I., Mizushima T., Yamamoto H., Doki Y., Mori M. A novel endoscopic fluorescent clip visible with near-infrared imaging during laparoscopic surgery in a porcine model. Surg Endosc 28 1984-1990 2014
96
Takeyama H., Yamamoto H, Hata T, Takahasi Y, Ohtsuka M, Nonaka R, Inoue A, Naito A, Matsumura T, Uemura M, Nishimura J, Takemasa I, Mizushima T, Doki Y, Mori M A novel single-stapling technique for colorectal anastomosis: a pre-ligation single-stapling technique (L-SST) in a porcine model. Surg Endosc Epub - 2014
97
Takiguchi S., Takata A., Murakami K., Miyazaki Y., Yanagimoto Y., Kurokawa Y., Takahashi T., Mori M., Doki Y. Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy. Gastric Cancer 17 200-205 2014
98
Tamari K., Hayashi K., Ishii H., Kano Y., Konno M., Kawamoto K., Nishida N., Koseki J., Fukusumi T., Hasegawa S., Ogawa H., Hamabe A., Miyo M., Noguchi K., Seo Y., Doki Y., Mori M., Ogawa K. Identification of chemoradiation-resistant osteosarcoma stem cells using an imaging system for proteasome activity. Int J Oncol 45 2349-2354 2014
99
Tamura S., Fujiwara Y., Kimura Y., Fujita J., Imamura H., Kinuta M., Yano M., Hiratsuka M., Kobayashi K., Okada K., Mori M., Doki Y. Prognostic information derived from RT-PCR analysis of peritoneal fluid in gastric cancer patients: results from a prospective multicenter clinical trial. J Surg Oncol 109 75-80 2014
100
Tanaka K., Takiguchi S., Miyashiro I., Hirao M., Yamamoto K., Imamura H., Yano M., Mori M., Doki Y. Impact of reconstruction method on visceral fat change after distal gastrectomy: results from a randomized controlled trial comparing Billroth I reconstruction and roux-en-Y reconstruction. Surgery 155 424-431 2014
101
Taniguchi T., Hirai K., Sumi R., Hayashi N., Maeda K., Ito T. Predictors of colonoscopy
use 1 year after colonoscopy: prospective study of surveillance behavior for colorectal
cancer. Health Psychol Behav Med 2 283-295 2014
102
Tomimaru Y., Ito T., Kawamoto K., Hama N., Wada H., Kobayashi S., Eguchi H., Tanemura M., Mori M., Doki Y., Nagano H. Clinical outcome of pancreas transplantation from marginal donors in Japan. Transplant Proc 46 954-957 2014
103
Tomimaru Y., Kobayashi S, Wada H, Hama N, Kawamoto K, Eguchi H, Kira T, Morii E, Doki Y, Mori M, Nagano H. Intrahepatic cholangiocarcinoma in a worker at an offset color proof-printing company: An autopsy case report. Hepatol Res Epub - 2014
104
Toyoda M., Ajiki T., Fujiwara Y., Nagano H., Kobayashi S., Sakai D., Hatano E., Kanai M., Nakamori S., Miyamoto A., Tsuji A., Kaihara S., Ikoma H., Takemura S., Toyokawa H., Terajima H., Morita S., Ioka T. Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004). Cancer Chemother Pharmacol 74 1295-1301 2014
105
Ueda M., Takahashi Y., Shinden Y., Sakimura S., Hirata H., Uchi R., Takano Y., Kurashige J., Iguchi T., Eguchi H., Sugimachi K., Yamamoto H., Doki Y., Mori M., Mimori K. Prognostic significance of high mobility group box 1 (HMGB1) expression in patients with colorectal cancer. Anticancer Res 34 5357-5362 2014
106
Uenishi T., Nagano H., Marubashi S., Hayashi M., Hirokawa F., Kaibori M., Matsui K., Kubo S. The long-term outcomes after curative resection for mass-forming intrahepatic cholangiocarcinoma associated with hepatitis C viral infection: A multicenter analysis by Osaka Hepatic Surgery Study Group. J Surg Oncol 110 176-181 2014
107
Wada H., Isobe M., Kakimi K., Mizote Y., Eikawa S., Sato E., Takigawa N., Kiura K., Tsuji K., Iwatsuki K., Yamasaki M., Miyata H., Matsushita H., Udono H., Seto Y., Yamada K., Nishikawa H., Pan L., Venhaus R., Oka M., Doki Y., Nakayama E. Vaccination with NY-ESO-1 overlapping peptides mixed with Picibanil OK-432 and montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen. J Immunother 37 84-92 2014
108
Wada H., Yamamoto H., Kim C., Uemura M., Akita H., Tomimaru Y., Hama N., Kawamoto K., Kobayashi S., Eguchi H., Umeshita K., Doki Y., Mori M., Nagano H. Association between ephrin-A1 mRNA expression and poor prognosis after hepatectomy to treat hepatocellular carcinoma. Int J Oncol 45 1051-1058 2014
109
Wada N., Kurokawa Y., Takiguchi S., Takahashi T., Yamasaki M., Miyata H., Nakajima K., Mori M., Doki Y. Feasibility of laparoscopy-assisted total gastrectomy in patients with clinical stage I gastric cancer. Gastric Cancer 17 137-140 2014
110
Wada N., Kurokawa Y., Nishida T., Takahashi T., Toyokawa T., Kusanagi H., Hirota S., Tsujinaka T., Mori M., Doki Y. Subgroups of patients with very large gastrointestinal stromal tumors with distinct prognoses: A multicenter study. J Surg Oncol 109 67-70 2014
111
Watanabe K., Sasaki I., Fukushima K., Futami K., Ikeuchi H., Sugita A., Nezu R., Mizushima T., Kameoka S., Kusunoki M., Yoshioka K., Funayama Y., Watanabe T., Fujii H., Watanabe M. Long-term incidence and characteristics of intestinal failure in Crohn's disease: a multicenter study. J Gastroenterol 49 231-238 2014
112
Watanabe M., Miyata H., Gotoh M., Baba H., Kimura W., Tomita N., Nakagoe T., Shimada M., Kitagawa Y., Sugihara K., Mori M. Total gastrectomy risk model: data from 20,011 Japanese patients in a nationwide internet-based database. Ann Surg 260 1034-1039 2014
113
Yamamoto H., Miyoshi N., Mimori K., Hitora T., Tokuoka M., Fujino S., Ellis HL., Ishii H., Noura S., Ohue M., Yano M., Doki Y., Mori M. MACC1 expression levels as a novel prognostic marker for colorectal cancer. Oncol Lett 8 2305-2309 2014
114
Yamasaki M., Miyata H., Miyazaki Y., Takahashi T., Kurokawa Y., Nakajima K., Takiguchi S., Mori M., Doki Y. Perioperative therapy for esophageal cancer. Gen Thorac Cardiovasc Surg 62 531-540 2014
115
Yamasaki M., Miyata H., Miyazaki Y., Takahashi T., Kurokawa Y., Nakajima K., Takiguchi S., Mori M., Doki Y. Evaluation of the nodal status in the 7th edition of the UICC-TNM classification for esophageal squamous cell carcinoma: proposed modifications for improved survival stratification : impact of lymph node metastases on overall survival after esophagectomy. Ann Surg Oncol 21 2850-2856 2014
116
Yoshioka Y., Kosaka N., Konishi Y., Ohta H., Okamoto H., Sonoda H., Nonaka R., Yamamoto H., Ishii H., Mori M., Furuta K., Nakajima T., Hayashi H., Sugisaki H., Higashimoto H., Kato T., Takeshita F., Ochiya T. Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat Commun 5 3591- 2014